Edition:
India

Aslan Pharmaceuticals Ltd (ASLN.OQ)

ASLN.OQ on NASDAQ Stock Exchange Global Market

3.21USD
2:29am IST
Change (% chg)

$0.07 (+2.23%)
Prev Close
$3.14
Open
$3.14
Day's High
$3.24
Day's Low
$3.14
Volume
1,678
Avg. Vol
5,335
52-wk High
$10.41
52-wk Low
$2.52

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -2.134
Jun '18 0.00 -2.233
Mar '18 0.00 -1.959
FY 2017 Dec '17 0.00 -3.358
Sep '17 0.00 -1.851
Jun '17 0.00 -2.299
Mar '17 0.00 -2.169
 
*Note: Units in Millions ofTaiwanese Dollars
**Note: Units in Taiwanese Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.48 33.70
P/E High - Last 5 Yrs. -- 44.98 49.87
P/E Low - Last 5 Yrs. -- 23.63 24.25
Beta -- 0.90 0.90
Price to Sales (TTM) 15.98 4.12 6.29
Price to Book (MRQ) 3.32 5.10 5.26
Price to Tangible Book (MRQ) 3.32 5.85 6.77
Price to Cash Flow (TTM) -- 24.01 24.98
% Owned Institutions -- 0.90 1.69

Dividends

  Company industry sector
Dividend Yield -- 1.49 1.40
Dividend Yield - 5 Year Avg -- 1.51 1.42
Dividend 5 Year Growth Rate -- 4.15 4.85
Payout Ratio(TTM) -- 43.91 41.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -100.00 4.31 12.75
Sales (TTM) vs TTM 1 Yr. Ago 4,341.80 4.07 5.84
Sales - 5 Yr. Growth Rate -- 10.91 11.23
EPS (MRQ) vs Qtr. 1 Yr. Ago -104.48 44.94 47.15
EPS (TTM) vs TTM 1 Yr. Ago 81.78 -- --
EPS - 5 Yr. Growth Rate -- 10.31 10.85
Capital Spending - 5 Yr. Growth Rate -- 15.88 15.20

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.15 2.25
Current Ratio (MRQ) 18.10 2.97 3.08
LT Debt to Equity (MRQ) 15.50 8.84 11.38
Total Debt to Equity (MRQ) 15.50 12.89 16.12
Interest Coverage (TTM) -15.86 33.79 29.47

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 53.68 53.81
Gross Margin - 5 Yr. Avg. -- 51.67 52.18
EBITD Margin (TTM) -156.26 -- --
EBITD - 5 Yr. Avg -- 17.96 12.87
Operating Margin (TTM) -157.49 14.31 6.20
Operating Margin - 5 Yr. Avg. -- 14.24 8.31
Pre-Tax Margin (TTM) -160.59 14.85 7.16
Pre-Tax Margin - 5 Yr. Avg. -- 14.68 8.61
Net Profit Margin (TTM) -160.59 11.08 3.30
Net Profit Margin - 5 Yr. Avg. -- 11.02 4.89
Effective Tax Rate (TTM) -- 23.02 22.91
Effective Tax Rate - 5 Yr. Avg. -- 23.16 23.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 957,645,487 842,398,385
Net Income/Employee (TTM) -- 113,564,537 99,842,801
Receivable Turnover (TTM) 89.37 5.71 5.71
Inventory Turnover (TTM) -- 2.61 3.47
Asset Turnover (TTM) 0.19 0.97 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -30.40 11.52 11.06
Return on Assets - 5 Yr. Avg. -- 12.92 12.20
Return on Investment (TTM) -31.58 14.95 14.45
Return on Investment - 5 Yr. Avg. -- 16.84 15.87
Return on Equity (TTM) -37.22 16.27 15.96
Return on Equity - 5 Yr. Avg. -- 17.77 17.00
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 92.11 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aslan Pharmaceuticals Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 2.10%
# of Holders: 4
Total Shares Held: 3,362,800
3 Mo. Net Change: -145,000
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 0
# Reduced Positions: 1
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.